BioVIE Drops After Phase 2, MSU Leads Hormonal Drug Modeling, Exercise After Cancer Cuts Recurrence, Rochester Leads Global Laser Science, and more...
Published: September 16, 2026
Duration: 11:37
(0:10): BioVie Shares Drop 16% After Mixed Phase 2 Results for Long COVID Treatment
(2:12): $12.8M NIH Grant Boosts Women's Hormonal Drug Modeling Initiative Led by Michigan State University
(4:37): Exercise Post-Cancer Treatment Cuts Recurrence, Boosts Survival: Major Study Finds
(6:56): Rochester to Lead Global Laser Science with $13.7M NSF Backing for World's Most Powerful Laser Facility
(9:06): Study Unveils ATP Synthase's Crucial Role in Calcium Homeostasis Beyond Energy Production
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: InvestorsHub
(2:12): $12.8M NIH Grant Boosts Women's Hormonal Drug Modeling Initiative Led by Michigan State University
(4:37): Exercise Post-Cancer Treatment Cuts Recurrence, Boosts Survival: Major Study Finds
(6:56): Rochester to Lead Global Laser Science with $13.7M NSF Backing for World's Most Powerful Laser Facility
(9:06): Study Unveils ATP Synthase's Crucial Role in Calcium Homeostasis Beyond Energy Production
To subscribe visit https://www.brief.news.
For more updates in your inbox each morning visit www.brief.news.
Image credit: InvestorsHub